Mirae Asset Global Investments Co., Ltd. Erasca, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Erasca, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 10,943 shares of ERAS stock, worth $27,685. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,943
Previous 9,460
15.68%
Holding current value
$27,685
Previous $12,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ERAS
# of Institutions
149Shares Held
216MCall Options Held
258KPut Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.7MShares$57.5 Million1.52% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD20.3MShares$51.4 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY17.9MShares$45.2 Million4.49% of portfolio
-
Logos Global Management LP San Francisco, CA15MShares$38 Million2.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.5MShares$36.7 Million0.63% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $309M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...